Updated Review,transport

The intricate dance of copper within the human body is meticulously orchestrated by specialized proteins, among which the ATP7B copper transporter peptides play a critical role. This vital protein, also known as the Wilson disease protein (WNDP), is a copper-transporting P1B-type ATPase (Cu-ATPase), essential for maintaining copper homeostasis in cells and the body as a whole. Understanding the function and structure of ATP7B is paramount, not only for comprehending normal physiological processes but also for unraveling the mechanisms behind genetic disorders like Wilson's disease.

The ATP7B gene provides the blueprint for this crucial protein, which is a member of the P-type cation transport ATPase family. This means ATP7B utilizes the energy derived from ATP hydrolysis to actively move ions, in this case, copper ions, across cellular membranes. Research has provided significant insights into the structure of ATP7B, with studies offering the first glimpse into its molecular architecture and functional mechanisms. The protein possesses several membrane-spanning domains and is characterized by six metal-binding domains (MBDs), each capable of binding a copper ion. These MBDs are crucial for the copper transport function of ATP7B, with the binding motifs closest to the channel being particularly important for this process.

ATP7B's primary function is to export cytosolic copper and deliver it to specific destinations. In the liver, a key organ for copper homeostasis, ATP7B is instrumental in sequestering excess copper into vesicles, which are then directed for excretion into bile. This process is vital for preventing the toxic accumulation of copper in hepatic cells. Beyond excretion, ATP7B also facilitates the delivery of copper to biosynthetic pathways, ensuring that copper is available for incorporation into essential copper-dependent enzymes. These enzymes are involved in a myriad of biological processes, including cellular respiration, antioxidant defense, and neurotransmitter synthesis.

The ATP7B copper transporter is particularly adept at regulating vesicular storage of Cu in mouse intestine, buffering Cu levels in enterocytes to maintain a range necessary for the formation of chylomicrons. This highlights its systemic importance beyond just liver function. Furthermore, studies have shown that ATP7B is involved in copper resistance in cancer cells and may play a role in autophagy-mediated copper clearance, suggesting potential therapeutic avenues.

Mutations in the ATP7B gene are the underlying cause of Wilson's disease, a rare but potentially fatal genetic disorder. In individuals with Wilson's disease, the dysfunctional ATP7B protein is unable to effectively transport copper out of the liver or incorporate it into proteins. This leads to a progressive buildup of copper in the liver, brain, and other organs, causing severe damage and a wide range of symptoms, including neurological and psychiatric disturbances, liver failure, and Kayser-Fleischer rings in the eyes. Direct measurement of ATP7B peptides can be highly effective in diagnosing Wilson's disease, often reducing diagnostic ambiguity.

The intricate copper relay path through the N-terminus of human copper transporter ATP7B has been a subject of extensive investigation using model systems like yeast. These studies aim to elucidate how Cu is efficiently channeled through the protein and its associated chaperones, such as antioxidant 1 copper chaperone (ATOX1), which targets ATP7B directly in the liver to transport copper.

Understanding the structure and function of ATP7B copper transporter and its associated peptides is crucial for developing effective diagnostic and therapeutic strategies for Wilson's disease and other copper-related disorders. Ongoing research into the protein's dynamics, its interaction with other molecules like LC3B, and the precise mechanisms of copper ion transmembrane transporter activity continues to shed light on this essential component of human physiology. The Human copper transporters ATP7B and ATP7A, in fact, are homologous copper-transporting P1B-type ATPases that collectively ensure cellular copper homeostasis.